Eunice Kennedy Shriver National Institute of Child Health and Human Development:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eunice Kennedy Shriver National Institute of Child Health and Human Development - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5169
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health, is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the fields of fields of reducing infant deaths, improving health of women, men and families learning. It offers research in clinical trials and clinical research, health education campaigns and programs, NICHD publications, scientific research planning and scientific resources. NICHD also provides funding support for training and career development activities at universities and other institutions. The institute offers its services for laboratory research, clinical trials and studies. NICHD is headquartered in Rockville, Maryland, the US.

Eunice Kennedy Shriver National Institute of Child Health and Human Development – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Cyprium Therapeutics Enters into Research and Development Agreement with Eunice Kennedy Shriver NICHD 11
SRI International Enters into Biological Testing Facility Contract with NICHD 12
Dimension Therapeutics Enters into R&D Agreement with Eunice Kennedy Shriver National Institute 13
Licensing Agreements 14
NICHD Enters into Licensing Agreement with Cyprium Therapeutics 14
Eunice Kennedy Shriver National Institute of Child Health and Human Development – Key Competitors 15
Eunice Kennedy Shriver National Institute of Child Health and Human Development – Key Employees 16
Eunice Kennedy Shriver National Institute of Child Health and Human Development – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Research And Development 18
Jan 06, 2017: Viriom Announces Collaboration with NIH on Zika and Other Major Viral Diseases 18
Government and Public Interest 19
Jul 02, 2018: Pregnancy Loss Occurs in 26 Percent of Zika-Infected Monkeys 19
Jun 13, 2018: New trans-NIH consortium aims to advance pediatric research on a global level 20
May 09, 2018: Dr. Boukrina of Kessler Foundation Explores Intervention for Reading Deficits After Stroke 21
Apr 11, 2018: NIH researchers crack mystery behind rare bone disorder 22
Apr 02, 2018: Elevated blood pressure before pregnancy may increase chance of pregnancy loss 23
Mar 29, 2018: NIH study may help explain why iron can worsen malaria infection 24
Mar 26, 2018: Atypical brain development observed in preschoolers with ADHD symptoms 25
Mar 26, 2018: Diuretic therapy for extremely preterm infants does not alleviate respiratory problems 26
Mar 12, 2018: CRISPR helps find new genetic suspects behind ALS/FTD 27
Mar 07, 2018: Antiviral drug not beneficial for reducing mother-to-child transmission of hepatitis B when added to existing preventatives 28
Feb 13, 2018: NIH-funded researchers identify risk factors for sleep apnea during pregnancy 29
Nov 13, 2017: Obesity during pregnancy may lead directly to fetal overgrowth, NIH study suggests 30
May 25, 2017: Investigator Lawrence T. Reiter, PhD, of The University of Tennessee Health Science Center Receives $418,000 Grant for New Antieplieptic Drug Treatment Study 31
Product News 32
03/23/2018: Male Birth Control Pill Shows Promise 32
03/18/2018: Dimethandrolone undecanoate shows promise as a male birth control pill 33
Feb 26, 2018: NIH researchers find a potential treatment for disorders involving excess red blood cells 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Key Facts 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Deals By Therapy Area, 2012 to YTD 2018 9
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Cyprium Therapeutics Enters into Research and Development Agreement with Eunice Kennedy Shriver NICHD 11
SRI International Enters into Biological Testing Facility Contract with NICHD 12
Dimension Therapeutics Enters into R&D Agreement with Eunice Kennedy Shriver National Institute 13
NICHD Enters into Licensing Agreement with Cyprium Therapeutics 14
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Key Competitors 15
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Key Employees 16
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Subsidiaries 17

List of Figures
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Eunice Kennedy Shriver National Institute of Child Health and Human Development, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

★海外企業調査レポート[Eunice Kennedy Shriver National Institute of Child Health and Human Development:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Aarti Drugs Ltd (AARTIDRUGS):企業の財務・戦略的SWOT分析
    Summary Aarti Drugs Ltd (ADL), a subsidiary of Aarti Group of Industries is a contract manufacturer of pharmaceutical products that offers therapeutic products, ingredients, bulk drugs, and chemicals. The company's products include active pharmaceutical ingredients, pharma intermediates, and special …
  • Bm-Bank Public Joint Stock Company
    Bm-Bank Public Joint Stock Company - Strategy, SWOT and Corporate Finance Report Summary Bm-Bank Public Joint Stock Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Cancer Genetics Inc (CGIX):企業の財務・戦略的SWOT分析
    Summary Cancer Genetics Inc (CGI) is a pharmaceutical company that offers diagnostic products and services enabling precision medicine in the field of oncology. It offers products such as CGH microarrays, next-generation sequencing and DNA-FISH Probes. The company's oncology tests and laboratory ser …
  • Copan Italia SpA:医療機器:M&Aディール及び事業提携情報
    Summary Copan Italia SpA (Copan Italia) is a medical equipment provider that offers lab consumables and diagnostic products. The company’s products include clinical products, lab automation products, and genetics, forensics, and lab consumable products, among others. Its lab automation products allo …
  • Coca-Cola HBC AG:企業の戦略・SWOT・財務情報
    Coca-Cola HBC AG - Strategy, SWOT and Corporate Finance Report Summary Coca-Cola HBC AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Yangarra Resources Ltd (YGR):石油・ガス:M&Aディール及び事業提携情報
    Summary Yangarra Resources Ltd (Yangarra) is an oil and gas company that explores, develops and produces oil and natural gas resources. The company owns and operates oil and gas properties in Medicine Hat, Central Alberta, and Jaslan. It has infrastructure and land holdings. Central Alberta producti …
  • Dragon Oil Plc:企業の戦略的SWOT分析
    Dragon Oil Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Bellerophon Therapeutics Inc (BLPH):企業の財務・戦略的SWOT分析
    Summary Bellerophon Therapeutics Inc (Bellerophon Therapeutics), formerly Bellerophon Therapeutics LLC is a clinical-stage biotherapeutics company that focuses on the development of therapies for the treatment of cardiopulmonary diseases. The company’s lead investigational cardiopulmonary product ca …
  • Mutuelle Generale de l’Education Nationale:企業の戦略的SWOT分析
    Mutuelle Generale de l'Education Nationale - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors an …
  • Cyclopharm Ltd (CYC):企業の財務・戦略的SWOT分析
    Cyclopharm Ltd (CYC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Canadian Solar Inc (CSIQ):企業の財務・戦略的SWOT分析
    Canadian Solar Inc (CSIQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • CorMedix Inc (CRMD):企業の財務・戦略的SWOT分析
    Summary CorMedix Inc (CorMedix) is a commercial-stage pharmaceutical company that develops and commercializes therapeutic products for prevention and treatment of cardiac, renal and infectious diseases. The company offers neutrolin, a non-antibiotic anti-infective developed as a preventative solutio …
  • California Water Service Group (CWT):企業の財務・戦略的SWOT分析
    Summary California Water Service Group (California Water Service) is a utility service provider that offers wastewater services and water operation and maintenance services. The utility provides services such as water and wastewater utility services, and operating water and wastewater systems servic …
  • Alphatec Holdings Inc (ATEC):医療機器:M&Aディール及び事業提携情報
    Summary Alphatec Holdings Inc (Alphatec) is a medical technology company that focuses on the design, development and marketing of spinal fusion technology products and solutions for the treatment of spine disorders. The company’s major products include anterior cervical plate system, posterior cervi …
  • Medical Transcription Billing Corp (MTBC):医療機器:M&Aディール及び事業提携情報
    Summary Medical Transcription Billing Corp (MTBC) is a healthcare IT company that offers web-based solutions and related business services. The company offers products such as electronic health records, practice management, patient engagement and mhealth. Its services include offers medical billing, …
  • Enel Americas SA:企業の戦略・SWOT・財務分析
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • MEDITE Cancer Diagnostics Inc (MDIT):医療機器:M&Aディール及び事業提携情報
    Summary MEDITE Cancer Diagnostics Inc (MEDITE), formerly CytoCore, Inc., specializes in the development, engineering, manufacturing and marketing of premium medical devices and consumables for detection, risk assessment and diagnosis of cancer and related diseases. Its major devices include ultrason …
  • China Longyuan Power Group Corporation Ltd (916):電力:M&Aディール及び事業提携情報
    Summary China Longyuan Power Group Corporation Ltd (CLPGC), a subsidiary of China Energy Investment Corporation Ltd, carries out design, development, construction, management and operation of wind farms. It generates and sells electricity to the local grid companies. The company also operates other …
  • Torque Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Torque Therapeutics Inc (Torque) is an immuno-oncology company focused on developing first-in-class deep primed T Cell therapeutics to cure cancer. Its product pipeline includes Deep IL-15 used for for hematologic and solid tumors; Deep IL-12 targeting solid tumors; and small-molecule Deep T …
  • TaiwanJ Pharmaceuticals Co Ltd (6549):製薬・医療:M&Aディール及び事業提携情報
    Summary TaiwanJ Pharmaceuticals Co Ltd (TaiwanJ) is a pharmaceutical company that develops and commercialize small molecules for unmet medical needs such as chronic organ inflammation of metabolic, autoimmune and infectious etiologies. It develops TLR4, a transmembrane protein that provides key medi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆